Archive for April, 2008

Committee for Medicinal Products for Human Use (CHMP) Recommends Janumet(TM)(sitagliptin/metformin) for EU Approval for Type 2 Diabetes

WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–April 24, 2008–Merck
Sharp & Dohme (MSD) today received a positive opinion from the
Committee for Medicinal Products for Human Use (CHMP) recommending
European approval for Janumet(TM) (sitagliptin/metformin, MSD), a new
option for the treatment of type 2 diabetes. Sitagliptin/metformin
delivers substantial glucose lowering through a combination of
sitagliptin, an incretin enhancer (DPP-4 inhibitor), and metformin,
with a low […]

TREDAPTIVE(TM) Recommended for EU Approval for the Treatment of Mixed Dyslipidemia or Primary Hypercholesterolemia

WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–April 24, 2008–Merck,
Sharp & Dohme (MSD) today announced that the Committee for Medicinal
Products for Human Use (CHMP) has recommended marketing approval for
TREDAPTIVE(TM) (nicotinic acid/laropiprant, MSD) 1000 mg / 20 mg
modified-release tablets for the treatment of mixed dyslipidemia or
primary hypercholesterolemia. TREDAPTIVE, the name of CORDAPTIVE(TM)
(ER niacin/laropiprant) in the European Union (EU), combines a
nicotinic […]

Pfizer on Track to Deliver Greater Shareholder Value, CEO Kindler Tells Shareholders

MEMPHIS, Tenn.–(BUSINESS WIRE)–April 24, 2008–Today at Pfizer’s
annual shareholder meeting, Chairman and Chief Executive Officer
Jeffrey B. Kindler detailed his plan to build on the Company’s
foundation to drive greater shareholder return.

“Operationally, in 2007, we took a series of significant actions
to better position Pfizer to meet our challenges and to seize the many
opportunities before […]

Arcadia Biosciences Contributes Technology License to the African Agricultural Technology Foundation to Develop Nitrogen Efficient and Salt Tolerant African Rice

Technology Donation to Foster Environmentally Sustainable Increase in Food Security and Productivity of African Farmers

Pfizer Animal Health Enters into Agreement to Acquire Animal Health Products from Schering-Plough

PARIS–(BUSINESS WIRE)–April 23, 2008–Pfizer Animal Health today
announced that it has entered into an agreement to acquire multiple
product franchises from Schering-Plough Corporation covering all major
animal health species including cattle, swine, equine, and companion
animal.
Specifically, Pfizer Animal Health will acquire from
Schering-Plough a number of animal health products for sale in the
European Economic Area covering the following categories:
–  Swine […]

Web Video Discovery Goes Mobile: Sony Ericsson Customers To Have Access To Over 150 Million Web Videos On Their Mobile Phones

vtap Mobile Video allows fast and intelligent search across entire Internet - FREE- On Sony Ericsson’s popular Fun & Downloads web portal

Affiliates of Sun European Partners, LLP Open Offices in Paris and Frankfurt

LONDON–(BUSINESS WIRE)–April 23, 2008–Sun European Partners,
LLP (”Sun European”), the European adviser to Sun Capital Partners,
Inc. (”Sun Capital”), a leading U.S.-based private investment firm,
today announced that two Sun affiliates have opened offices in Paris
and Frankfurt to support the continued growth of Sun’s private equity
activities in Europe.
Sun European opened its office in London in July 2004, which
currently […]

Scientists Warn of EU legislation: Reduced Number of Pesticides Will Lead to Resistant Pests

LJUBLJANA, Slovenia–(BUSINESS WIRE)–April 23, 2008–Leading
European agricultural experts gathered in Ljubljana (Slovenia) on 22
April 2008 in order to present the Slovenian EU presidency with a
declaration on potential risks of the proposed EU legislation. The
scientists from seven countries fear that reducing the available range
of pesticides could lower their efficiency as it is likely that it
will increase resistance.

[…]

The International Myeloma Foundation Says Thalidomide Approval in Europe Could Provide Survival Benefits to Newly Diagnosed Myeloma Patients

The European Commission Grants Marketing Authority for Melphalan-Prednisone-Thalidomide Regimen

Thalidomide Pharmion(TM) Granted Full Marketing Authorization for Treatment of Newly Diagnosed Multiple Myeloma in the European Union

BOUDRY, Switzerland–(BUSINESS WIRE)–April 21, 2008–Celgene
International Sarl (NASDAQ: CELG) announced that Thalidomide Pharmion
has been granted full marketing authorization by the European
Commission for use in combination with melphalan and prednisone as a
treatment for patients with newly diagnosed multiple myeloma. In June
2007, the European Commission granted the Company’s REVLIMID(R) full
marketing authorization as the first oral treatment in more […]

Next Page »